We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Genzyme Cited for Thymoglobulin Manufacturing Operations
Genzyme Cited for Thymoglobulin Manufacturing Operations
November 7, 2007
Genzyme used components and intermediates for the production of bulk Thymoglobulin lots that exceeded prespecified bioburden and pathogenic microorganism limits, according to a Sept. 19 FDA warning letter.